Literature DB >> 31444865

PIP2 alters of Ca2+ currents in acutely dissociated supraoptic oxytocin neurons.

Matthew K Kirchner1, William E Armstrong1, Dongxu Guan1, Yoichi Ueta2, Robert C Foehring1.   

Abstract

Magnocellular neurosecretory cells (MNCs) occupying the supraoptic nucleus (SON) contain voltage-gated Ca2+ channels that provide Ca2+ for triggering vesicle release, initiating signaling pathways, and activating channels, such as the potassium channels underlying the afterhyperpolarization (AHP). Phosphotidylinositol 4,5-bisphosphate (PIP2 ) is a phospholipid membrane component that has been previously shown to modulate Ca2+ channels, including in the SON in our previous work. In this study, we further investigated the ways in which PIP2 modulates these channels, and for the first time show how PIP2 modulates CaV channel currents in native membranes. Using whole cell patch clamp of genetically labeled dissociated neurons, we demonstrate that PIP2 depletion via wortmannin (0.5 μmol/L) inhibits Ca2+ channel currents in OT but not VP neurons. Additionally, it hyperpolarizes voltage-dependent activation of the channels by ~5 mV while leaving the slope of activation unchanged, properties unaffected in VP neurons. We also identified key differences in baseline currents between the cell types, wherein VP whole cell Ca2+ currents display more inactivation and shorter deactivation time constants. Wortmannin accelerates inactivation of Ca2+ channels in OT neurons, which we show to be mostly an effect on N-type Ca2+ channels. Finally, we demonstrate that wortmannin prevents prepulse-induced facilitation of peak Ca2+ channel currents. We conclude that PIP2 is a modulator that enhances current through N-type channels. This has implications for the afterhyperpolarization (AHP) of OT neurons, as previous work from our laboratory demonstrated the AHP is inhibited by wortmannin, and that its primary activation is from intracellular Ca2+ contributed by N-type channels.
© 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society.

Entities:  

Keywords:  Ca2+ channels; PIP2; oxytocin; supraoptic nucleus

Mesh:

Substances:

Year:  2019        PMID: 31444865      PMCID: PMC6708058          DOI: 10.14814/phy2.14198

Source DB:  PubMed          Journal:  Physiol Rep        ISSN: 2051-817X


Introduction

Voltage‐gated Ca2+ (CaV) channels regulate transmembrane Ca2+ influx in neurons throughout the brain by opening in response to membrane depolarization. Elevated Ca2+ as a result of this influx activates neurotransmission, second messenger pathways, other ion channels, and gene expression (Catterall 2011). There are five types of Ca2+ currents described in neurons, named L‐, N‐, P/Q‐, R‐, and T‐type. These currents are generated by channels containing α‐subunits named CaV1.1‐1.4 (L‐type), CaV2.1 (P/Q‐type), CaV2.2 (N‐type), CaV2.3 (R‐Type), and CaV3.1‐3.3 (T‐Type) (Simms and Zamponi 2014; Campiglio and Flucher 2015; Dolphin 2018). The channels can be divided into high‐voltage (HVA) and low‐voltage activated (LVA) channels based on their activation voltage dependence. T‐type channels are the only members of the LVA group while the other four make up the HVA group. In addition to their voltage dependence, these channels are modulated by an array of mechanisms including auxiliary β‐subunits, calmodulin, G‐proteins, and intracellular Ca2+. The plasma membrane‐bound phospholipid phosphatidylinositol 4,5 bisphosphate (PIP2) regulates both KV and CaV channels (Suh et al. 2010; Hille et al. 2015). PIP2 is a long‐chain phospholipid found on the inner leaflet of cell membranes and it is critically involved in the maintenance of the IP3/DAG second messenger pathway. PIP2 is generated and broken down in the cell membrane. This production is cyclical, and results in a basal production of PIP2 regardless of a cell’s current PIP2 demand (Xu et al. 2003). In addition to the IP3/DAG pathway, PIP2 controls a wide range of cellular functions including organization of filamentous actin, cellular differentiation, exocytosis, and ion channel maintenance (Eberhard et al. 1990; Sun et al. 1999; Hilgemann et al. 2001). PIP2’s modulation of ion channels is well known. KCNQ (KV7) channels are the best documented example (Li et al. 2005; Suh et al. 2006; Kim et al. 2017a), but evidence also exists for modulation of heterologously expressed CaV channels by PIP2. TsA201 cell lines transfected with different CaV channels show drastically reduced L‐ and N‐type currents acceleration of their inactivation after PIP2 depletion (Suh et al. 2010). Retarding of time‐dependent run‐down of P/Q‐type current occurs when excess PIP2 is supplied to the cells (Wu et al. 2002). Magnocellular neurosecretory cells (MNCs) are large (~25 μm) neurons that secrete oxytocin (OT) or vasopressin (VP) via action potential‐triggered exocytosis, and which express L‐, N‐, P/Q‐, R, and T‐type voltage‐dependent Ca2+currents (Poulain and Wakerley 1982; Foehring and Armstrong 1996; Fisher and Bourque 1996). Our interest in PIP2 modulation of CaV channels is spurred by previous work of our group on PIP2’s modulation of Ca2+‐dependent afterhyperpolarizations (AHPs) in these neurons. We determined that PIP2 was required for AHP generation in OT, but not VP neurons (Kirchner et al. 2017). Our previous study suggested that PIP2 regulates AHP generation by modulating CaV channels in OT neurons but did not identify which Ca2+ channels were affected or by what mechanisms. Furthermore, we found that both medium (mAHP) and slow (sAHP) Ca2+‐dependent afterhyperpolarizations (AHPs) are coupled tightly to N‐type channel currents in OT neurons, whereas in VP neurons the mAHP is coupled to N‐type channels and the sAHP is coupled to R‐type channels (Kirchner et al. 2018). Given the numerous observations of PIP2/N‐type interactions in previous work (Wu et al. 2002; Delmas and Brown 2005; Michailidis et al. 2007), and the dependence of MNC AHPs on PIP2 and N‐currents, we tested for the modulation of whole cell and N‐type Ca2+ currents by PIP2 in acutely dissociated MNCs from transgenic Wistar rats expressing either red fluorescent or green fluorescent protein in OT or VP neurons, respectively. To our knowledge, this work provides the first direct evidence for PIP2 modulation of specific CaV channels in native neurons.

Methods

Ethical approval and animals

These studies were performed on transgenic female Wistar rats containing the AVP‐eGFP fusion and/or the OT‐mRFP1 fusion transgenes (Ueta et al. 2005; Katoh et al. 2011). These rats weighed between 140 and 230 g and aged 6–12 weeks old. The UTHSC IACUC review board approved all experiments and the experiments conform to the principles of UK regulations as described in (Drummond 2009). Animals were on an ad libitum diet. For use in experiments, rats were deeply anesthetized with ketamine/xylazine (10% xylazine; 100 mg kg−1), perfused through the heart with artificial cerebrospinal fluid (aCSF) with NaCl replaced by 210 mmol/L sucrose, then decapitated via guillotine. The brains were then removed and sliced for use in whole cell patch clamp electrophysiology. The study was performed only on female rats since the primary focus of the laboratory was plastic changes that occur in these neurons throughout the reproductive cycle (Stern and Armstrong 1996; Teruyama and Armstrong, 2002, 2005; Wang et al. 2018).

Acutely dissociated neuron preparation

After removal, the brain was placed under a dissecting microscope for the dissection of supraoptic tissue. The brain was placed with the ventral surface up. Using iris scissors, a horizontal strip of tissue was excised from the ventral surface of the brain containing the supraoptic nucleus attached to the optic chiasm/tract. This strip of tissue was divided into four even strips of optic tract with hypothalamus attached. These explants were then submerged in aCSF bubbled with 95% O2‐5% CO2. After resting for a minimum of 30 min, tissue was transferred to a glass chamber warmed by a water bath at 34 °C. The chamber containing the tissue was aCSF + 1 mg/mL of Streptomyces griseus Type XIV enzyme (Sigma‐Aldrich) bubbled with 95% O2‐5% CO2 for 24–30 min. After enzymatic treatment, tissue was transferred to a glass test tube containing a solution (in mmol/L): 140 Na+ Isethionate, 2 KCl, 0.1 CaCl2, 4 MgCl2, 20 Glucose, 10 HEPES, pH balanced to 7.2 with NaOH. The tissue was then titrated through flame‐polished glass pipettes three times in successfully smaller diameter pipettes. The supernatant was removed and plated onto a culture dish, which was placed into the chamber of an inverted microscope (Nikon Diaphot 300). The cells were allowed 7 min to settle on the dish. A background flow of Hanks buffered saline solution (HBSS) was administered and cells were visualized (Fig. 1A). Imaging occurred on the microscope with DIC and fluorescence with two filter blocks for excitation of either AVP‐eGFP (470–490 nm) or OT‐mRFP1 (510–560 nm).
Figure 1

Wortmannin depletion of PIP2 inhibits whole cell Ca2+ currents in OT neurons but not VP neurons. (A) (left), SON neuron visualized with differential interference optics or (right) green light excitation (510–560 nm) filter, revealing the OT‐mRFP label. (B) To test whether the I–V relationship of whole cell Ca2+ currents generated from ramps reflected the currents seen with steps to specific voltages, we plotted I–V curves from OT neurons (n = 5) from both steps (upper left) and ramps (upper right). The step protocol consisted of a family of steps from a holding potential of −60 mV to +50 mV in 10 mV increments for 500 msec before returning to baseline. (lower left) Current traces in the same cell in response to the step protocol. The ramp protocol ramped from −60 mV to +50 mV at a rate of 0.33 mV/msec. (lower right) Currents in response to the ramp protocol. (C) Summary plot of averaged currents from normalized ramps and steps in OT neurons before and after wortmannin (n = 5 cells). All traces are normalized to the control trace. Note the similarity in the I–V relationships between the two protocols under control conditions and similar effects of wortmannin with both voltage protocols. (D) (left) Whole cell Ca2+ currents generated via ramp protocol from an mRFP1‐labeled OT neuron before and after wortmannin (0.5 µmol/L). (right) Summary graph of wortmannin’s effect on OT neurons. Wortmannin inhibited whole cell Ca2+ currents by 52.2 ± 8% (n = 12, **P < 0.01). (E) (left) Whole cell Ca2+ currents generated via ramp protocol from a GFP‐labeled VP neuron before and after wortmannin (0.5 µmol/L). (right) Summary graph of wortmannin’s effect on VP neurons. Wortmannin had no significant effect on whole cell VP Ca2+ currents (n = 5, P > 0.5). (F) Same experiment as Fig. 1D except with diC8‐PIP2 (30 µmol/L) supplemented in the internal solution. (left) Whole cell Ca2+ currents generated via ramp protocol from an mRFP1‐labeled OT neuron before and after wortmannin. (right) Summary graph of wortmannin’s effect on OT neurons in the presence of diC8‐PIP2. Wortmannin had no significant effect on whole cell OT Ca2+ currents when diC8‐PIP2 was dialyzed through the pipette (n = 13, P > 0.6). (G) (left) Whole cell Ca2+ currents generated via ramp protocol from an OT neuron before and after application of the PI3K inhibitor LY294, 002. (right) Summary graph of LY294, 002’s effect on OT neurons. LY294,002 had no significant effect on whole cell OT Ca2+ currents (n = 8, P > 0.6). (H) Summary chart comparing the % inhibition in response to respective drug applications. Cells without diC8‐PIP supplementation demonstrated significantly reduced current after wortmannin compared to cells that had diC8‐PIP dialysis or LY294,002 application (**P < 0.001). (I) Steady‐state activation plots for OT (left; n = 6) and VP (right; n = 6) neurons. These curves represent averages of neurons derived from ramp protocols. While neither cell type demonstrates changes in slope, after wortmannin OT neurons demonstrate a significant hyperpolarizing shift of −4.6 mV measured at the half activation voltage (V 1/2).

Wortmannin depletion of PIP2 inhibits whole cell Ca2+ currents in OT neurons but not VP neurons. (A) (left), SON neuron visualized with differential interference optics or (right) green light excitation (510–560 nm) filter, revealing the OT‐mRFP label. (B) To test whether the I–V relationship of whole cell Ca2+ currents generated from ramps reflected the currents seen with steps to specific voltages, we plotted I–V curves from OT neurons (n = 5) from both steps (upper left) and ramps (upper right). The step protocol consisted of a family of steps from a holding potential of −60 mV to +50 mV in 10 mV increments for 500 msec before returning to baseline. (lower left) Current traces in the same cell in response to the step protocol. The ramp protocol ramped from −60 mV to +50 mV at a rate of 0.33 mV/msec. (lower right) Currents in response to the ramp protocol. (C) Summary plot of averaged currents from normalized ramps and steps in OT neurons before and after wortmannin (n = 5 cells). All traces are normalized to the control trace. Note the similarity in the I–V relationships between the two protocols under control conditions and similar effects of wortmannin with both voltage protocols. (D) (left) Whole cell Ca2+ currents generated via ramp protocol from an mRFP1‐labeled OT neuron before and after wortmannin (0.5 µmol/L). (right) Summary graph of wortmannin’s effect on OT neurons. Wortmannin inhibited whole cell Ca2+ currents by 52.2 ± 8% (n = 12, **P < 0.01). (E) (left) Whole cell Ca2+ currents generated via ramp protocol from a GFP‐labeled VP neuron before and after wortmannin (0.5 µmol/L). (right) Summary graph of wortmannin’s effect on VP neurons. Wortmannin had no significant effect on whole cell VP Ca2+ currents (n = 5, P > 0.5). (F) Same experiment as Fig. 1D except with diC8‐PIP2 (30 µmol/L) supplemented in the internal solution. (left) Whole cell Ca2+ currents generated via ramp protocol from an mRFP1‐labeled OT neuron before and after wortmannin. (right) Summary graph of wortmannin’s effect on OT neurons in the presence of diC8‐PIP2. Wortmannin had no significant effect on whole cell OT Ca2+ currents when diC8‐PIP2 was dialyzed through the pipette (n = 13, P > 0.6). (G) (left) Whole cell Ca2+ currents generated via ramp protocol from an OT neuron before and after application of the PI3K inhibitor LY294, 002. (right) Summary graph of LY294, 002’s effect on OT neurons. LY294,002 had no significant effect on whole cell OT Ca2+ currents (n = 8, P > 0.6). (H) Summary chart comparing the % inhibition in response to respective drug applications. Cells without diC8‐PIP supplementation demonstrated significantly reduced current after wortmannin compared to cells that had diC8‐PIP dialysis or LY294,002 application (**P < 0.001). (I) Steady‐state activation plots for OT (left; n = 6) and VP (right; n = 6) neurons. These curves represent averages of neurons derived from ramp protocols. While neither cell type demonstrates changes in slope, after wortmannin OT neurons demonstrate a significant hyperpolarizing shift of −4.6 mV measured at the half activation voltage (V 1/2).

Electrophysiology

Recording pipettes (2.5–5 MΩ) were pulled from borosilicate glass with an outer diameter of 1.5 mm using a P‐1000 Flaming/Brown horizontal micropipette puller (Sutter Instruments, Sovato, CA). The pipettes were coated to near the tip in bee’s wax to minimize capacitive artifacts during recordings. The pipette internal solution consisted of (in mmol/L): 180 N‐methyl‐d‐glucamine, 4 MgCl2, 40 HEPES, 2 Na‐ATP, 0.4 Mg‐GTP, 12 phosphocreatine, 0.1 leupeptin, 10 EGTA; pH 7.2 adjusted with TEA‐OH; 270–280 mOsmol (kg H2O)−1. Cells were perfused with a background solution of HBSS. After achieving a whole cell patch, a Ca2+ current‐isolating solution was delivered to the cells via a gravity‐driven multibarrel array of glass capillary tubing (150 µm OD) mounted on a manipulator planted opposite to the recording pipette. Ca2+ currents were isolated with a solution in which Ba2+ replaced Ca2+ as the charge carrier. This was done because Ba2+ produces larger currents compared to Ca2+, it blocks K+ channels, and it minimizes the activation of intracellular Ca2+‐dependent mechanisms. This solution contained (in mmol/L): 10 Glucose, 10 HEPES, 5 BaCl2, 150 TEA‐Cl, pH 7.2 balanced with TEA‐OH. Drugs were administered using this same multibarrel array. Pharmacological agents included wortmannin (0.5 µmol/L; Tocris Biosciences) to deplete PIP2, the L‐type blocker nifedipine (Nif, 5 µmol/L; Sigma‐Aldrich), the N‐type blocker ω‐conotoxin GVIA (CnTx GVIA, 1 µmol/L; Alomone Labs), the P/Q‐type blocker agatoxin IVA (AgTxIVA, 0.5 µmol/L; Alomone Labs), and the R‐type blocker SNX‐482 (0.3 µmol/L; Alomone Labs). Some experiments were performed with water‐soluble synthetic diC8‐PIP2 in the pipette (30 µmol/L; Echelon Biosciences Inc.). Recordings were filtered at 2 kHz. Series resistance was corrected online by 60–85%. All recordings in this study were obtained in voltage clamp. We used a ramp protocol at 0.33 mV/ms to evoke isolated Ca2+ currents at voltages from −60 mv to +50 mV. We also used a step protocol to evaluate time constants of activation, inactivation, and tail currents (a family of steps from −60 mV to +50 mV in 10 mV increments, 500 msec step duration,) (Fig. 2). All neurons were also tested in 400 µmol/L extracellular Cd2+ to confirm measurement of Ca2+ currents at the end of the recording. Cells whose series resistance exceeded 20 MΩ or changed more than 20% during the duration of the recording were excluded from analysis.
Figure 2

Wortmannin does not significantly affect activation or deactivation time constants in OT and VP neurons. (A) Measurements of activation time constants (τ) determined from Ca2+ currents generated via a step protocol from a holding potential of −60 mV to potentials between −30 mV and +40 mV in OT (left) and VP (right) neurons. Activation of the current was well fit by a single exponential function (first order). Activation τ was not significantly altered in either cell type after wortmannin application (P > 0.05). (B) We fit tail currents to a double exponential function, interpreting the first, faster τ value as the deactivation τ. Deactivation τ was unaffected by wortmannin (P > 0.05), but there was a significant difference between OT and VP neurons (*P < 0.05) (Two‐way repeated measures ANOVA).

Wortmannin does not significantly affect activation or deactivation time constants in OT and VP neurons. (A) Measurements of activation time constants (τ) determined from Ca2+ currents generated via a step protocol from a holding potential of −60 mV to potentials between −30 mV and +40 mV in OT (left) and VP (right) neurons. Activation of the current was well fit by a single exponential function (first order). Activation τ was not significantly altered in either cell type after wortmannin application (P > 0.05). (B) We fit tail currents to a double exponential function, interpreting the first, faster τ value as the deactivation τ. Deactivation τ was unaffected by wortmannin (P > 0.05), but there was a significant difference between OT and VP neurons (*P < 0.05) (Two‐way repeated measures ANOVA). To evaluate statistical differences between groups, we primarily used a two‐way repeated measures ANOVA to evaluate the differences between OT and VP neurons before and after drug application (Figs. 1, 2, 3). We also used a repeated measures ANOVA to analyze wortmannin’s effect on isolated and blocked N‐type channels (Figs. 4 and 5), to analyze the prepulse facilitation data before and after wortmannin, and for comparing groups with and without diC8‐PIP2 in the pipette (Fig. 6). We used a Sidak test for all post hoc analyses. All statistics were performed in SPSS (IBM).
Figure 3

Inactivation properties of OT and VP neurons before and after wortmannin. (A) Ca2+ currents in response to voltage steps from a holding potential of −60 mV to +40 mV in OT cells before (top) and after (bottom) wortmannin application. Note the difference in scale for the wortmannin currents. We expanded the scale of the wortmannin traces because the greatly decreased current amplitude makes it difficult to see the inactivation changes at the original scale. (B) Ca2+ currents in response to voltage steps from a holding potential of −60 mV from −30 mV to +40 mV in a VP cell before (top) and after (bottom) wortmannin application. The inactivation time course in VP neurons was faster compared to their OT counterparts in controls, but slower and less complete compared to OT neurons after wortmannin. (C and D) We compared wortmannin’s (0.5 µmol/L) effect on % Inactivation and inactivation time constants of Ca2+ currents in OT (C) and VP (D) neurons from a holding potential of −60 mV to a step of −30 mV to +40 mV. There were significant differences in baseline % Inactivation and inactivation time constants of the currents between OT and VP neurons at holding potentials between ‐10 and +30 mV (*P < 0.05, comparison not explicitly shown). OT neurons revealed significantly increased % Inactivation and faster time constants after wortmannin. Note the lack of wortmannin modulation in VP cells. Significance values are marked with asterisks as follows: *P < 0.05, **P < 0.01, and ***P < 0.001. % Inactivation was measured as: ((Peak‐Steady State)/Peak) × 100.

Figure 4

PIP2 significantly reduces pharmacologically isolated N‐type Ca2+ currents in OT neurons. PIP2 depletion via wortmannin (0.5 µmol/L) inhibited isolated N‐type currents (A and C) while unaffecting the Ca2+ channel currents remaining after N‐type channels were blocked with CnTx GVIA (1 µmol/L) (B and D). (A) Ca2+ channel current from a neuron (black trace) where N‐type channels were isolated by blocking the other HVA Ca2+ channels (gray trace) with L‐type blocker nifedipine (Nif, 5 µmol/L), P/Q‐type blocker agatoxin IVA (AgTx‐IVA, 0.5 µmol/L), and R‐type blocker SNX‐482 (0.3 µmol/L). The neurons were subsequently treated with wortmannin (red trace), which reduced the isolated N‐type current. (B) Ca2+ channel current from a neuron (black trace) where N‐type channels were blocked with conotoxin GVIA (CnTx GVIA, 1 µmol/L) (gray trace). The neurons were subsequently treated with wortmannin (red trace) to evaluate PIP2 depletion effects on the remaining HVA Ca2+ channel currents. (C) Summary data of peak Ca2+ channel currents from ramps. Isolation of N‐type currents resulted in a 69.6 ± 6% reduction in whole cell current. Wortmannin significantly inhibited the isolated N‐type current by 44 ± 6% (*P < 0.05). Red traces represent individual neurons while the black trace is the mean ± SEM. (D) Summary data of peak Ca2+ channel currents from ramps. Block of N‐type currents resulted in a 45.6 ± 6% reduction in whole cell current. Wortmannin slightly inhibited the current remaining after GVIA by 12 ± 1%, but this was not statistically significant (P > 0.05). Red traces represent individual neurons while the black trace is the average.

Figure 5

Wortmannin significantly reduced % Inactivation and accelerates inactivation of N‐Type currents in OT neurons. PIP2 depletion via wortmannin (0.5 µmol/L) reduced the % Inactivation of the isolated N‐current (A, C and E) but not Ca2+ currents remaining after N‐type channels were blocked (B, D and F) in OT neurons. Significant differences between control and N‐type isolation are marked with a pound symbol (# P < 0.05) while an asterisk (*P < 0.05) marks the significant difference between N‐type currents before and after wortmannin. (A) Summary data of % Inactivation under control conditions (black points), N‐type channel isolation (gray points), and N‐type isolation + wortmannin (red points). (B) Summary data of % Inactivation under control conditions (black points), N‐type channel block (gray points), and N‐type block + wortmannin (red points). No significant differences occurred between any groups (P > 0.05). (C) Summary data of inactivation time constants under control conditions (black points), N‐type channel isolation (gray points), and N‐type isolation + wortmannin (red points). (D) Summary data of inactivation time constants under control conditions (black points), N‐type channel block (gray points), and N‐type block + wortmannin (red points). No significant differences occurred between any groups (P > 0.05). (Ei) Representative traces of Ca2+ channel currents generated by a 500 msec voltage step to −10 mV from a holding potential of −60 mV. Trace A is a baseline Ca2+ channel current, trace B is the pharmacologically isolated N‐type current, and trace C is the isolated N‐type current after wortmannin. (Eii) Traces B′ and C′ are the same respective traces as in Ei, except scaled to the peak of the control to highlight the effect of PIP2 depletion on % Inactivation independent of the reduction in current. (Fi) Representative traces of Ca2+ channel currents generated by a 500 msec voltage step to −10 mV. Trace A is a baseline Ca2+ channel current. Trace B is the whole cell Ca2+ channel current with blocked N‐type current. Trace C is the current after subsequent addition of wortmannin. (Fii) Traces B′ and C′ are the same respective traces scaled to the peak of the control. In contrast to (E), wortmannin did not significantly change the % Inactivation when N‐type current was blocked.

Figure 6

PIP2 is necessary for voltage‐dependent facilitation of Ca2+ current on OT neurons. We tested the effects of PIP2 depletion on facilitation of Ca2+ channel currents by a depolarizing prepulse (c.f., Bean 1989). Ca2+ currents were evoked with a step to from −60 mV to −5 mV in OT neurons. Current was then evoked by the same test pulse but following a 30‐msec prepulse to +120 mV. We performed this two‐step protocol under control conditions (left) and in the presence of wortmannin (right), with (upper) and without (lower) diC8‐PIP2 in the pipette. (A) Example of Ca2+ currents with and without the prepulse, before and after wortmannin with the corresponding voltage protocol provided (bottom). (B) Summary data for the effects of prepulse, wortmannin, and diC8‐PIP2 in the pipette on the current peak (pA) and % facilitation. (left) Wortmannin inhibited peak Ca2+ channel currents when diC8‐PIP2 was absent (**P < 0.01). Inclusion of a prepulse significantly increased the peak current whether diC8‐PIP2 was absent (# P < 0.05) or present (ǂ P < 0.05) in the internal solution. (middle) Neither wortmannin nor diC8‐PIP2 affected the steady‐state amplitude of currents before and after a prepulse. (right) Histogram depicts % facilitation caused by the prepulse. Wortmannin significantly prevents the facilitation in standard solution (*P < 0.05). diC8‐PIP2 in the pipette prevents wortmannin’s inhibition of the facilitation.

Inactivation properties of OT and VP neurons before and after wortmannin. (A) Ca2+ currents in response to voltage steps from a holding potential of −60 mV to +40 mV in OT cells before (top) and after (bottom) wortmannin application. Note the difference in scale for the wortmannin currents. We expanded the scale of the wortmannin traces because the greatly decreased current amplitude makes it difficult to see the inactivation changes at the original scale. (B) Ca2+ currents in response to voltage steps from a holding potential of −60 mV from −30 mV to +40 mV in a VP cell before (top) and after (bottom) wortmannin application. The inactivation time course in VP neurons was faster compared to their OT counterparts in controls, but slower and less complete compared to OT neurons after wortmannin. (C and D) We compared wortmannin’s (0.5 µmol/L) effect on % Inactivation and inactivation time constants of Ca2+ currents in OT (C) and VP (D) neurons from a holding potential of −60 mV to a step of −30 mV to +40 mV. There were significant differences in baseline % Inactivation and inactivation time constants of the currents between OT and VP neurons at holding potentials between ‐10 and +30 mV (*P < 0.05, comparison not explicitly shown). OT neurons revealed significantly increased % Inactivation and faster time constants after wortmannin. Note the lack of wortmannin modulation in VP cells. Significance values are marked with asterisks as follows: *P < 0.05, **P < 0.01, and ***P < 0.001. % Inactivation was measured as: ((Peak‐Steady State)/Peak) × 100. PIP2 significantly reduces pharmacologically isolated N‐type Ca2+ currents in OT neurons. PIP2 depletion via wortmannin (0.5 µmol/L) inhibited isolated N‐type currents (A and C) while unaffecting the Ca2+ channel currents remaining after N‐type channels were blocked with CnTx GVIA (1 µmol/L) (B and D). (A) Ca2+ channel current from a neuron (black trace) where N‐type channels were isolated by blocking the other HVA Ca2+ channels (gray trace) with L‐type blocker nifedipine (Nif, 5 µmol/L), P/Q‐type blocker agatoxin IVA (AgTxIVA, 0.5 µmol/L), and R‐type blocker SNX‐482 (0.3 µmol/L). The neurons were subsequently treated with wortmannin (red trace), which reduced the isolated N‐type current. (B) Ca2+ channel current from a neuron (black trace) where N‐type channels were blocked with conotoxin GVIA (CnTx GVIA, 1 µmol/L) (gray trace). The neurons were subsequently treated with wortmannin (red trace) to evaluate PIP2 depletion effects on the remaining HVA Ca2+ channel currents. (C) Summary data of peak Ca2+ channel currents from ramps. Isolation of N‐type currents resulted in a 69.6 ± 6% reduction in whole cell current. Wortmannin significantly inhibited the isolated N‐type current by 44 ± 6% (*P < 0.05). Red traces represent individual neurons while the black trace is the mean ± SEM. (D) Summary data of peak Ca2+ channel currents from ramps. Block of N‐type currents resulted in a 45.6 ± 6% reduction in whole cell current. Wortmannin slightly inhibited the current remaining after GVIA by 12 ± 1%, but this was not statistically significant (P > 0.05). Red traces represent individual neurons while the black trace is the average. Wortmannin significantly reduced % Inactivation and accelerates inactivation of N‐Type currents in OT neurons. PIP2 depletion via wortmannin (0.5 µmol/L) reduced the % Inactivation of the isolated N‐current (A, C and E) but not Ca2+ currents remaining after N‐type channels were blocked (B, D and F) in OT neurons. Significant differences between control and N‐type isolation are marked with a pound symbol (# P < 0.05) while an asterisk (*P < 0.05) marks the significant difference between N‐type currents before and after wortmannin. (A) Summary data of % Inactivation under control conditions (black points), N‐type channel isolation (gray points), and N‐type isolation + wortmannin (red points). (B) Summary data of % Inactivation under control conditions (black points), N‐type channel block (gray points), and N‐type block + wortmannin (red points). No significant differences occurred between any groups (P > 0.05). (C) Summary data of inactivation time constants under control conditions (black points), N‐type channel isolation (gray points), and N‐type isolation + wortmannin (red points). (D) Summary data of inactivation time constants under control conditions (black points), N‐type channel block (gray points), and N‐type block + wortmannin (red points). No significant differences occurred between any groups (P > 0.05). (Ei) Representative traces of Ca2+ channel currents generated by a 500 msec voltage step to −10 mV from a holding potential of −60 mV. Trace A is a baseline Ca2+ channel current, trace B is the pharmacologically isolated N‐type current, and trace C is the isolated N‐type current after wortmannin. (Eii) Traces B′ and C′ are the same respective traces as in Ei, except scaled to the peak of the control to highlight the effect of PIP2 depletion on % Inactivation independent of the reduction in current. (Fi) Representative traces of Ca2+ channel currents generated by a 500 msec voltage step to −10 mV. Trace A is a baseline Ca2+ channel current. Trace B is the whole cell Ca2+ channel current with blocked N‐type current. Trace C is the current after subsequent addition of wortmannin. (Fii) Traces B′ and C′ are the same respective traces scaled to the peak of the control. In contrast to (E), wortmannin did not significantly change the % Inactivation when N‐type current was blocked. PIP2 is necessary for voltage‐dependent facilitation of Ca2+ current on OT neurons. We tested the effects of PIP2 depletion on facilitation of Ca2+ channel currents by a depolarizing prepulse (c.f., Bean 1989). Ca2+ currents were evoked with a step to from −60 mV to −5 mV in OT neurons. Current was then evoked by the same test pulse but following a 30‐msec prepulse to +120 mV. We performed this two‐step protocol under control conditions (left) and in the presence of wortmannin (right), with (upper) and without (lower) diC8‐PIP2 in the pipette. (A) Example of Ca2+ currents with and without the prepulse, before and after wortmannin with the corresponding voltage protocol provided (bottom). (B) Summary data for the effects of prepulse, wortmannin, and diC8‐PIP2 in the pipette on the current peak (pA) and % facilitation. (left) Wortmannin inhibited peak Ca2+ channel currents when diC8‐PIP2 was absent (**P < 0.01). Inclusion of a prepulse significantly increased the peak current whether diC8‐PIP2 was absent (# P < 0.05) or present (ǂ P < 0.05) in the internal solution. (middle) Neither wortmannin nor diC8‐PIP2 affected the steady‐state amplitude of currents before and after a prepulse. (right) Histogram depicts % facilitation caused by the prepulse. Wortmannin significantly prevents the facilitation in standard solution (*P < 0.05). diC8‐PIP2 in the pipette prevents wortmannin’s inhibition of the facilitation.

Results

PIP2 depletion inhibits isolated Ca2+ currents in OT neurons

We previously demonstrated that PIP2 depletion via wortmannin inhibited whole cell Ca2+ currents in slices from wild‐type Sprague–Dawley rats (OT neurons) (Kirchner et al. 2017), and that N‐type channels were most closely coupled to AHPs, especially in OT neurons (Kirchner et al. 2018). Here we examined the nature of this modulation in acutely dissociated MNCs, a preparation where space clamp artifacts are greatly minimized. Wortmannin inhibits both PI4Kα, and PI3K, enzymes that act as the rate‐limiting steps for PIP2 and PIP3 production, respectively (Nakanishi et al. 1995) and effectively depleting PIP2 from the neurons. Here we tested wortmannin’s effects under conditions where voltage was better controlled and solutions could be rapidly changed using dissociated neurons from transgenic Wistar rats. To determine the consistency between ramp and step protocol I–V relationships, we plotted data from both protocols together (Fig. 1B). The traces obtained from all cells were averaged and then normalized to the maximal current. We first did two comparisons: control steps versus control ramps and wortmannin steps versus wortmannin ramps (Fig. 1C). We determined that the ramp protocol provides an I–V curve that accurately reflects one plotted from peak currents generated in the step protocol in each case. We observed the following time course for wortmannin effects on CaV currents: Cells responded to wortmannin approximately 10–30 sec after drug delivery was initiated. An initial fast stage of inhibition occurred over 1–5 sec and was followed by the Ca2+ current settling into steady‐state by 30 sec. Measurements of the drug effects were taken during this steady‐state. Wortmannin (1 µmol/L) inhibited ramp‐generated Ca2+ current amplitudes by 52.2 ± 8% in OT neurons (n = 12; P < 0.001; Fig. 1D). Consistent with our previous observations in slices (Kirchner et al. 2017), wortmannin failed to inhibit ramp‐generated Ca2+ currents in VP neurons (n = 13; P > 0.4; Fig. 1E). The wortmannin effect was prevented when the water soluble, synthetic PIP2 analog dic8‐PIP2 (30 µmol/L) was supplied to the cells via the patch pipette (n = 5; P > 0.5; Fig. 1F). Because wortmannin inhibits PIP3 production (via PI3K) in addition to PIP2 production (via PI4Kα), we tested the highly specific PI3K blocker, LY294,002 on the Ca2+ currents. LY294,002 produced no significant inhibition of the current (n = 8; P > 0.3; Fig. 1G). This experiment increased confidence that wortmannin is inhibiting Ca2+ currents by depleting PIP2. Wortmannin also inhibited a much larger percentage of current compared to wortmannin with diC8‐PIP2 present the patch pipette, and compared to LY294,002 (P < 0.01; Fig. 1H). In addition to an effect of PIP2 depletion on current amplitude, we observed a leftward shift in the voltage‐dependent activation for OT neurons (Fig. 1I). To determine the steady‐state voltage dependence of activation, we generated a plot from ramps wherein currents were converted to conductance (G): . Every point from the ramp‐generated current was calculated to G/GMax, using a Boltzmann equation and plotted versus voltage (Fig. 3E). The Boltzmann equation used was: V 0.5 represents half activation and k represents the slope factor. Wortmannin negatively shifted V 0.5 for activation by −4.6 mV (n = 5; P < 0.05). There was no change in the slope of the curve (control 6.14 ± 0.01 vs. wortmannin 5.94 ± 0.01; P > 0.5). VP neurons demonstrated no changes in V 0.5 (control −15.8 vs. wortmannin −16.1) or slope (control 6.34 ± 0.01 vs. wortmannin 6.10 ± 0.01) (Fig. 1I).

PIP2 effects on Ca2+ channel gating

We generated Ca2+ currents using a step protocol to measure the kinetics of current activation, deactivation, and inactivation as a function of membrane voltage. At all membrane potentials measured, wortmannin had no significant effect on activation τ in either OT or VP neurons (n = 5) (Fig. 2A). Wortmannin also had no significant effect on the deactivation τ measured from tail currents at −70 mV (P > 0.05). However, in control solution, the deactivation τ was significantly slower in OT versus VP neurons (P < 0.05, Fig. 2B). We next measured both percent inactivation (% Inactivation) and the inactivation time constants for Ca2+ channel currents. We operationally defined % Inactivation as the percent change in current between peak and steady‐state values. We used this measure in addition to time constants because in these cells, Ca2+ channel currents do not fully inactivate during steps, even up to 5 sec duration. This is particularly relevant to OT neurons. As a result, time constant measurements in OT neurons under control conditions are likely underestimated, but we report them because the kinetics of inactivation clearly change significantly after wortmannin. Because longer step durations increased current run‐down over time, we opted to use a 500 msec step and measure the time constant as well as % Inactivation within this step. The time constant was measured using a monoexponential fit. We observed significant increases in % Inactivation and inactivation time constants in OT neurons in the presence of wortmannin at potentials ranging from −30 to +40 mV (10 mV increments) (P < 0.05, 0.01; Fig. 3A and C). Some steady‐state current remained after wortmannin (Fig. 5E), which we measured at the end of the pulse. VP neurons were unaffected by wortmannin application in this regard, at any potential (Fig. 3B and D). Additionally, VP neurons displayed significantly higher baseline % Inactivation and inactivation time constants compared to their OT counterparts (P < 0.05; Data not plotted). This baseline difference is apparent in the control traces of Fig. 3A and B.

Modulation of N‐type current in OT neurons

As noted earlier, there is a strong precedence for modulation and even the necessity of PIP2 for N‐type channel activation using expression systems (Michailidis et al. 2007; Suh et al. 2010). In previous work, we observed that specific Ca2+ channel types couple to each AHP component, and specifically, that N‐type channels couple to AHPs in OT neurons (Kirchner et al. 2018). We therefore isolated N‐type currents by using a cocktail of 5 µmol/L Nif (blocks L‐type), 0.5 µmol/L AgTxIVA (blocks P/Q‐type), and 0.3 µmol/L SNX‐482 (blocks R‐type). Ca2+ channel currents were generated from ramps and application of Nif + AgTxIVA + SNX‐482 resulted in a 69.6 ± 6% reduction of the whole cell peak current (Fig. 4A and C). We interpret this remaining current as the isolated N‐type current. Wortmannin inhibited this isolated N‐type by 44 ± 6% (n = 5; P < 0.05). We also did the complementary experiment, testing wortmannin’s ability to affect non‐N–type Ca2+ currents after N‐type block with 1 µmol/L CnTx GVIA. CnTx GVIA resulted in 46 ± 6% reduction of whole cell current, but wortmannin did not significantly inhibit the CnTx GVIA‐treated current (n = 5; P > 0.05) (Fig. 4B and D). Because wortmannin increased the inactivation of whole cell Ca2+ currents, we evaluated how much of this inactivation could be attributed to effects at N‐type versus all other HVA currents (Fig. 5). We found that N‐type isolation resulted in a significant reduction in the % Inactivation at −30, −20, and −10 mV (n = 7; P < 0.05; Fig. 5A). Application of wortmannin to isolated N‐type currents resulted in significant inhibition of % Inactivation at almost all measured potentials (n = 7; P < 0.05; Fig. 5A). When measuring inactivation time constants, isolation of N‐type current resulted in significant reductions at −20, −10, and 0 mV (n = 7; P < 0.05; Fig. 5C). Application of wortmannin to the isolated N‐type currents shortened time constants significantly at potentials of −10, +10, and +20 mV (n = 7; P < 0.05; Fig. 5C). This is most apparent when the isolated N‐type current and the wortmannin‐treated current were scaled to the control amplitude, where rapid inactivation was apparent (Fig. 5Eii). Significance at individual voltages was determined with a Sidak post hoc test. In contrast to the isolated N‐type currents, we observed no significant changes for % Inactivation or inactivation time constants measured at any potential from the currents remaining after N‐type channels were blocked (n = 5; P > 0.05; Fig. 5B and D). Again, this is apparent when the traces with CnTx GVIA and wortmannin were scaled to the control amplitude (Fig. 5Fii).

PIP2 and facilitation of Ca2+ channels

To further elucidate voltage‐dependent mechanisms of PIP2 modulation, we explored the possibility of its involvement in Ca2+ channel facilitation. Facilitation in this context is classically defined as an increased Ca2+ current following application of a brief, strong positive prepulse (to +120 mV) (Bean 1989). In previous studies, such a prepulse has been shown to reverse G protein‐mediated neurotransmitter modulation to various degrees (Aosaki and Kasai 1989; Bean 1989; Foehring 1996; Colecraft et al. 2000; Stewart and Foehring 2000; Schober et al. 2010). While such a prepulse is not physiological, it is a vital method in testing potential allosteric modulation by PIP2. To test whether PIP2 affects facilitation, we generated Ca2+ currents in OT neurons with and without a 30‐ms prepulse to +120 mV from −60 mV and evaluated facilitation before and after wortmannin. Insertion of a prepulse significantly increased the peak Ca2+ channel current by 17.4 ± 5% (facilitation: P < 0.05; n = 5; Fig. 6). Application of wortmannin inhibited the overall peak current (P < 0.01). In the presence of wortmannin, the prepulse failed to significantly increase peak current, modulating it by only 4.3 ± 3% (P > 0.05; Fig. 6). In other words, facilitation was significantly reduced by wortmannin compared to controls (n = 5; P < 0.05; Fig. 6). The prepulse did not affect steady‐state current (P > 0.05; Fig. 6B). We executed the same experiment described above with diC8‐PIP2 in the patch pipette. Under these conditions, the prepulse significantly facilitated peak current amplitude (P < 0.05; Fig. 6B), and wortmannin failed to significantly inhibit peak or steady‐state currents, consistent with previous experiments. In diC8‐PIP2, wortmannin did not significantly alter facilitation of peak current amplitude (diC8‐PIP2: control 22.7 ± 3% wortmannin 14.9 ± 3%; P > 0.1) or steady‐state current (Fig. 6B). These data suggest that facilitation is compromised after PIP2 depletion but that excess PIP2 has no further effect on facilitation relative to control PIP2 levels.

Discussion

In this study, we pursued three aims: (1) to determine if PIP2 modulates Ca2+ currents in native MNCs; (2) to determine the mechanisms underlying the effects of PIP2 on Ca2+ currents; and (3) to determine if PIP2 specifically modulated the N‐type channel, which we had shown to be a critical source of Ca2+ for generation of AHPs in OT neurons of the SON (Kirchner et al. 2018). In this study, we provide the first direct evidence for PIP2 modulation of specific CaV channels in native neurons. Previous work has characterized this relationship meticulously in expression systems (Gamper et al. 2004; Suh et al. 2010; Vivas et al. 2013). Additionally, indirect evidence exists in acutely dissociated bullfrog sympathetic ganglion neurons, where CaV currents are modulated by type II luteinizing hormone–releasing hormone in the absence of a PLC inhibitor (Wu et al. 2002). Our primary finding is that inhibition of Ca2+ current amplitudes after application of wortmannin in acutely dissociated OT (but not VP) neurons of Wistar transgenic rats is blocked when the patch pipette contained diC8‐PIP2, affirming that wortmannin’s effect on Ca2+ channel currents is related to PIP2 depletion. Additionally, the specific PI3K blocker LY294,002 failed to inhibit currents. In contrast to OT neurons, wortmannin had no effect on VP neuron currents. These results are consistent with our previous observations in slices of wild‐type Sprague‐Dawley rats (Kirchner et al. 2017). Finally, our results show that the PIP2 modulation is primarily exerted on N‐type Ca2+ channels. Interestingly, we also observed a hyperpolarizing shift in the voltage‐dependent activation of whole cell Ca2+ currents. This result is consistent with previous reports in which PIP2 depletion resulted in a leftward shift of voltage‐dependent activation of N‐type channels (Suh et al. 2010). In contrast, increased PIP2 levels resulted in a hyperpolarizing shift in voltage activation of Kv7 channels (Kim et al. 2016). While it is clear that depletion of PIP2 has effects on voltage‐dependent activation of Ca2+ currents in OT neurons, the direction and amount of this change would not account for dramatic inhibition of Ca2+ current we observed with PIP2 depletion (i.e., the leftward shift in activation observed with PIP2 depletion would tend to increase current at a given voltage). We also found no effect of wortmannin on the time course of activation or deactivation in OT neurons. In contrast, we observed a significant increase in % Inactivation and the rate of inactivation in OT neurons in the presence of wortmannin. While Ca2+ currents in VP neurons were unaffected by wortmannin, under control conditions, VP neurons demonstrated significantly stronger and faster inactivation at depolarized potentials compared to their OT counterparts. In addition, the deactivation τ was smaller in VP neurons than OT under basal conditions. This suggests the two cell types differ in Ca2+ channel family and/or subunit populations. This hypothesis is backed by previous observations in which the percent of current blocked by HVA Ca2+ channel toxins among unidentified MNCs (Fisher and Bourque 1995; Foehring and Armstrong 1996) was highly variable. A later study examining the mRNA levels of Ca2+ channels in OT versus VP neurons showed that OT neurons contained higher levels of N‐type mRNA (Glasgow et al. 1999). This same study demonstrated that mRNA levels for specific Ca2+ channels and their β subunits varied greatly across individual cells of the same cell type, providing further explanation for variability observed in the amount of current inhibited by pharmacological CaV channel blockers. Interestingly, a recent report showed that N‐type channels in VP neuronal terminals contain a β 2 subunit absent in OT neurons (Ortiz‐Miranda et al. 2010). This subunit is known to greatly alter the biophysical properties of the channel, including its inactivation kinetics (Campiglio and Flucher 2015). Although reports indicate β 2 subunit mRNA amount is approximately double in OT neurons (Glasgow et al. 1999), these measurements reflect the mRNA and not actual translation. Furthermore, while the β 2 subunit may not associate with N‐type channels in VP neuronal terminals, it is unknown whether there are β 2/N‐Type interactions in other VP cellular compartments. Indeed, the presence of β subunits, including β 2, determine N‐type channel sensitivity to PIP2 depletion in expression systems (Suh et al. 2012). Consistent with different Ca2+ channel subunit composition in OT versus VP neurons, we found that % Inactivation was significantly higher in VP neurons under control conditions (Fig. 3). Our earlier work made it clear that the presence of PIP2 allowed for more robust Ca2+ channel currents involved in the generation of AHPs (Kirchner et al. 2017), and we subsequently determined that N‐type channels were the Ca2+ source for OT AHPs (Kirchner et al. 2018). Additionally, PIP2 modulation of N‐type channels has been described in other cell types (Suh et al. 2010; Vivas et al. 2013; Kim et al. 2017b). We therefore focused our efforts on the modulation of specific channel types, and found that wortmannin affected isolated N‐type currents, but that no significant inhibition of current occurred after block of N‐type channels. Furthermore, we observed significant increases in inactivation τ and the % Inactivation of isolated N‐type currents after wortmannin, while these were unaffected after GVIA‐blocked N‐type Ca2+ currents. These data demonstrate that N‐type channels are the main Ca2+ channel target of PIP2 modulation in OT neurons. The inactivation changes following PIP2 depletion are small compared to inhibition of the current peak amplitude, and thus seem unlikely to account for the large inhibition of Ca2+ currents we observe. This observation is consistent with those in tsA‐201 cells in which there were large depressions of currents after PIP2 depletion but relatively small changes in gating (Suh et al. 2010). Suh et al. (2010) suggested that with reduced PIP2, fewer channels were available to open. This is similar to Bean (1989) hypothesis that G‐protein interactions shift Ca2+ channels into a “reluctant” mode for channel opening and can be converted to “willing” channels by voltage‐dependent removal of G‐protein inhibition (see also Foehring 1996). PIP2 may also encourage or be permissive for the opening of N‐type Ca2+ channels, as demonstrated by our data on facilitation (Fig. 6). Inclusion of a depolarized prepulse immediately prior to current generation resulted in marked facilitation of the peak current, an effect which is blocked by the application of wortmannin. Excess PIP2 (due to inclusion in the pipette) prevents this effect but results in no further increase in current, suggesting that PIP2 must be present for facilitation to occur. Wortmannin prevents the facilitation and elevated PIP2 levels prevent (or at least reduce) wortmannin’s effect. Thus, it appears PIP2 levels are needed for voltage‐dependent facilitation to occur, perhaps through allosteric effects. Future studies will be required to determine the nature of this relationship.

Conflict of Interest

None declared.
  43 in total

1.  Differential occurrence of reluctant openings in G-protein-inhibited N- and P/Q-type calcium channels.

Authors:  H M Colecraft; P G Patil; D T Yue
Journal:  J Gen Physiol       Date:  2000-02       Impact factor: 4.086

2.  Differential modulation of N-type calcium channels by micro-opioid receptors in oxytocinergic versus vasopressinergic neurohypophysial terminals.

Authors:  Sonia I Ortiz-Miranda; Govindan Dayanithi; Cristina Velázquez-Marrero; Edward E Custer; Steven N Treistman; José R Lemos
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

Review 3.  Pathways modulating neural KCNQ/M (Kv7) potassium channels.

Authors:  Patrick Delmas; David A Brown
Journal:  Nat Rev Neurosci       Date:  2005-11       Impact factor: 34.870

4.  Enhancement of calcium-dependent afterpotentials in oxytocin neurons of the rat supraoptic nucleus during lactation.

Authors:  Ryoichi Teruyama; William E Armstrong
Journal:  J Physiol       Date:  2005-05-05       Impact factor: 5.182

5.  Specificity in the interaction of high-voltage-activated Ca2+ channel types with Ca2+-dependent afterhyperpolarizations in magnocellular supraoptic neurons.

Authors:  Matthew K Kirchner; Robert C Foehring; Joseph Callaway; William E Armstrong
Journal:  J Neurophysiol       Date:  2018-07-18       Impact factor: 2.714

Review 6.  Neuronal voltage-gated calcium channels: structure, function, and dysfunction.

Authors:  Brett A Simms; Gerald W Zamponi
Journal:  Neuron       Date:  2014-04-02       Impact factor: 17.173

Review 7.  Electrophysiology of hypothalamic magnocellular neurones secreting oxytocin and vasopressin.

Authors:  D A Poulain; J B Wakerley
Journal:  Neuroscience       Date:  1982-04       Impact factor: 3.590

8.  Rapid chemically induced changes of PtdIns(4,5)P2 gate KCNQ ion channels.

Authors:  Byung-Chang Suh; Takanari Inoue; Tobias Meyer; Bertil Hille
Journal:  Science       Date:  2006-09-21       Impact factor: 47.728

9.  Pentobarbital inhibition of human recombinant alpha1A P/Q-type voltage-gated calcium channels involves slow, open channel block.

Authors:  A Schober; E Sokolova; K J Gingrich
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

10.  PIP₂ hydrolysis is responsible for voltage independent inhibition of CaV2.2 channels in sympathetic neurons.

Authors:  Oscar Vivas; Hector Castro; Isabel Arenas; David Elías-Viñas; David E García
Journal:  Biochem Biophys Res Commun       Date:  2013-02-08       Impact factor: 3.575

View more
  1 in total

1.  Erratum.

Authors: 
Journal:  Physiol Rep       Date:  2019-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.